Correlation Between Gain Therapeutics and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Gain Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Arrowhead Pharmaceuticals.
Diversification Opportunities for Gain Therapeutics and Arrowhead Pharmaceuticals
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gain and Arrowhead is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days Gain Therapeutics is expected to under-perform the Arrowhead Pharmaceuticals. In addition to that, Gain Therapeutics is 1.39 times more volatile than Arrowhead Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 4,047 in Arrowhead Pharmaceuticals on August 31, 2024 and sell it today you would lose (1,432) from holding Arrowhead Pharmaceuticals or give up 35.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gain Therapeutics vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| Gain Therapeutics |
| Arrowhead Pharmaceuticals |
Gain Therapeutics and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Arrowhead Pharmaceuticals
The main advantage of trading using opposite Gain Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. Cue Biopharma | Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Lantern Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |